Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
22.19
+0.04 (0.16%)
Oct 30, 2025, 11:42 AM EDT
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $73.69 billion as of October 30, 2025. Its market cap has decreased by -3.74% in one year.
Market Cap
73.69B
Enterprise Value
67.88B
Revenue
8.20B
Ranking
n/a
PE Ratio
27.46
Stock Price
$22.19
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 73.69B, an increase of 2,846.54%. That is a compound annual growth rate of 10.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 73.69B | 0.56% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | 87.57B | 72.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 588.69M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 337.25M |
| CytoDyn | 320.50M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 291.52M |